#MismatchRepairDeficient - Twitter Hashtag

over 1 year ago

Findings from a phase 2 study show that neoadjuvant PD-1 blockade w/ dostarlimab led to sustained clinical complete response in a substantial proportion of pts w/ early-stage #MismatchRepairDeficient solid tumours Read the news in the #ESMODailyReporter🔗 https://t.co/dsl0Xv8X92

myESMO's tweet photo. Findings from a phase 2 study show that neoadjuvant PD-1 blockade w/ dostarlimab led to sustained clinical complete response in a substantial proportion of pts w/ early-stage #MismatchRepairDeficient solid tumours

Read the news in the #ESMODailyReporter🔗 https://t.co/dsl0Xv8X92 https://t.co/4x2y9Y2lqK

0

6

1

0

1K

David Henry @davidhenrymd

over 4 years ago

#PD1Blockade in #MismatchRepairDeficient, Locally Advanced #RectalCancer - complete remission!👇 https://t.co/9dT5LA8IIW @AndreaCercek @MSKCancerCenter

0

2

0

Karol Polom @polom_karol

over 4 years ago

#PD-1 Blockade in #MismatchRepairDeficient, Locally Advanced #RectalCancer all 12 patients CCR, no other therapy than immunotherapy. Longer observation needed. #MSI @colo_research @me4_so @NEJM https://t.co/kMdQS3SNVF

0

3

0